Originally published by our sister publication, Pain Medicine News.
People with rheumatic disease who are taking immunosuppressant therapy to manage their symptoms should strongly consider getting an additional COVID-19 vaccine dose beyond the CDC’s current recommendations, according to new guidance from the American College of Rheumatology (ACR).
The ACR’s most recent update to the “COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and Musculoskeletal